Niche tracks can produce single-category champions, but for a category leader to grow into a platform enterprise, it must surmount three peaks: scale, diversification, and profitability. In August, Chenxing Technology (formerly known as Atom Robot) knocked on the door of the Hong Kong Stock Exchange's Chapter 18C listing regime for a second time. Born out of Tianjin University's parallel robot R&D system, this company established a firm foothold in industrial automation circles years ago under the "Atom" name. Following its rebranding in June, it has been attempting to shed the label of a "single-category parallel robot maker" and pivot toward a broader narrative of becoming a high-speed robotics platform. Judging by market share data, it truly qualifies as a rare standout in China's niche segments — based on 2025 shipment volumes, it commands a 20.4% share of the domestic parallel robot market, ranking first, and 7.7% globally, placing second. But flip through the prospectus, and the flip side of high growth reveals itself: recurring earnings volatility, sustained pressure on operating cash flow, and persistent losses in new product lines. For a hard-tech new listing, the core question left for the capital markets is whether the "category champion" halo can be smoothly transmitted to a multi-category platform strategy.

Revenue and gross margin trending up vs. earnings and cash flow trending down

Chenxing Technology is a high-speed industrial robotics company dedicated to the research, development, production, sales, and service of high-speed, high-reliability robots. Its product matrix spans four major series: parallel robots, high-speed selective compliance assembly robot arms (SCARA), heavy-duty collaborative robots (cobots), and embodied intelligent robots. Looking through its core financial metrics, as a "category champion" in the robotics space, the upward trajectory of revenue and gross margin is worth anticipating, yet the "foundation" of profitability remains unconsolidated. According to the prospectus, from 2023 to 2025, Chenxing's revenue grew from RMB 93 million to RMB 253 million, a two-year increase of approximately 172% with a compound annual growth rate of 64.4%; gross margin improved from 17.0% to 30.5%. In the first half of 2026, revenue reached RMB 135 million, up another 42.79% year-over-year. Looking at this curve alone, it's hard not to be impressed by its slope. However, the income statement tells a different rhythm — losses of RMB 39.25 million in 2023, expanding to RMB 47.07 million in 2024, barely turning profitable at RMB 739,000 in 2025, then slipping back into a loss of RMB 28.8 million in the first half of 2026. Two years of losses, one year of razor-thin profit, and six months of renewed bleeding form a textbook "rollercoaster curve." Notably, the quality of that RMB 739,000 profit in 2025 was largely attributable to RMB 8.88 million in government subsidies received that year. Excluding subsidies, the operating level remained loss-making. Chenxing candidly acknowledged in the prospectus that it expects a net loss of approximately RMB 21.4 million for the full year 2026.

What deserves deeper scrutiny than book profits is the shift in cash flow and receivables. From 2023 to the first half of 2026, net operating cash flow stood at RMB -14.86 million, RMB -6.59 million, RMB -23.16 million, and RMB -28.56 million respectively, showing accelerating outflows. Meanwhile, trade receivables and notes receivable ballooned from RMB 13.38 million in 2024 to RMB 71.71 million in the first half of 2026, growing at a pace far exceeding revenue growth. Book revenue keeps climbing while cash on hand keeps shrinking — this is the most dangerous signal in Chenxing's financial data. So where did the profits go? The answer lies in the product mix. The parallel robot, as the core business, has remained a stable profit contributor with consistently rising revenue; however, its share of total revenue has declined from 64.2% in 2023 to 43.0% in the first half of 2026, indicating that growth is increasingly driven by new products still in their cultivation phase. Among these, the high-speed SCARA robot is currently in a "trading losses for market share" stage, with gross margins persistently negative from 2024 through the first half of 2026; the heavy-duty cobot saw gross margin as low as -198.9% in 2023 and only turned positive in 2024. The embodied intelligent robot currently contributes negligible revenue and remains in early development. Clearly, as the product structure diversifies, Chenxing has laid its expansion costs bare for all to see.

From the above, it's evident that Chenxing's growth story mirrors a cross-section of the high-growth narrative in China's robotics sector: revenue and gross margins trending up while earnings and cash flow trend down; the product matrix expanding ever wider while operational cash generation remains unproven. For the company, the true moat lies not just in defending parallel robot profitability, but in transitioning SCARA, cobots, and embodied intelligence from "trading losses for share" to "trading technology for profit," converting accounts receivable back into cash, and steering scale growth back into a positive operating cycle.

Sector growing at double digits, yet cutthroat competition and cyclical headwinds cap expansion potential

Examining industry dynamics, the high-speed industrial robotics sector Chenxing operates in is itself a mix of opportunities and challenges — offering long-term upside from manufacturing flexibility upgrades, import substitution, and AI-powered embodied intelligence on one hand, while facing constraints from niche market ceilings, intense competition, and downstream cyclicality on the other. Starting with the core parallel robot business, China's parallel robot shipment value was approximately RMB 1.3192 billion in 2025, projected to grow at a 12.5% compound annual growth rate to RMB 2.3768 billion by 2030. This is not a massive super-sector but a precisely defined category targeting high-speed picking, sorting, and packing in specific scenarios. Benefiting from rising automation penetration in food and beverage, pharmaceuticals, lithium batteries, and photovoltaics, the domestic market is maintaining steady double-digit growth. But the market size is inherently limited — if the company stayed here alone, long-term growth would gradually hit a ceiling. This is precisely the underlying logic behind Chenxing's proactive expansion into SCARA, cobots, and embodied intelligence: a single niche cannot sustain a listed company's long-term growth narrative.

When extending outward, however, Chenxing steps into a red ocean. While both the SCARA and cobot tracks are growing robustly — China's SCARA market was valued at RMB 3.6 billion in 2025, expected to grow at a 13.5% CAGR to RMB 6.8 billion by 2030; China's cobot shipment value was RMB 3.8 billion, projected to grow at a 33.4% CAGR to RMB 16 billion — the SCARA arena is already heavily fortified by domestic and international players such as Inovance, Estun, and Epson, with leading manufacturers having accumulated years of advantages in supply chains, costs, distribution channels, and customer case histories. The cobot space is equally crowded, with price wars erupting from time to time. Looking further out, the embodied intelligence wave adds a new option value to high-speed robotics. Iterations in AI vision, motion planning, and multi-machine coordination have the potential to unlock new applications in precision assembly and flexible workstations; however, it's crucial to distinguish between trend and performance — the technology roadmap is still rapidly evolving, and prototype validation, scenario refinement, and mass production scale-up all require considerable time, making meaningful near-term revenue and profit contributions unlikely.

Moreover, the prospects and risks of Chenxing's sector are equally clear. At the industry level, the tailwinds include a determined direction toward flexible manufacturing upgrades in China, with many traditional production lines shifting from rigid, fixed equipment to rapidly reconfigurable high-speed robotic solutions; rising maturity of the domestic supply chain giving local players natural advantages in rapid iteration, customer proximity, and customized adaptation; and policy support for smart manufacturing and self-reliance in high-end equipment providing long-term environmental backing. On the risk side, manufacturing capital expenditure is strongly cyclical — once expansion paces in downstream new energy, 3C, and food industries decelerate, robot orders will come under direct pressure; the hardware segment is prone to product homogenization, with new entrants continuously flooding in and compressing the industry's overall gross margin midpoints; and embodied intelligence and humanoid-related directions demand heavy R&D investment with unclear commercialization timelines, easily trapping companies in an "endless spending, uncertain returns" investment vortex. The robotics sector has never lacked compelling stories, but what truly carries value is the ability to turn stories into steady orders, and then convert those orders into hard cash flow. For companies like Chenxing — setting out from segment leadership to break into broader territory — it has received a ticket to a larger market, not a guaranteed winning berth.

Final thoughts

In summary, it's clear that Chenxing Technology is a company with a solid technical foundation — rooted in Tianjin University's parallel robot team, with R&D spending consistently maintained around 10%-20% of revenue, and achieving the No. 1 shipment ranking in its niche, with a product matrix spanning from parallel robots to embodied intelligence. But the capital markets never reward those with merely "solid foundations" — they only reward those who can convert that foundation into profits. Chenxing's IPO is essentially a validation test of whether a niche segment leader can bridge category boundaries. The Chapter 18C rule provides a listing pathway, but whether it can achieve profitability in new categories after raising funds will be the defining watershed for this stock's long-term value.